Systemic chemotherapy remains the backbone of many cancer treatments. Due to its untargeted nature and the severe side effects it can cause, numerous nanomedicine approaches have been developed to overcome these issues. However, targeted delivery of therapeutics remains challenging. Engineering microrobots is increasingly receiving attention in this regard. Their functionalities, particularly their motility, allow microrobots to penetrate tissues and reach cancers more efficiently. Here, we highlight how different microrobots, ranging from tailor-made motile bacteria and tiny bubble-propelled microengines to hybrid spermbots, can be engineered to integrate sophisticated features optimised for precision-targeting of a wide range of cancers. Towards this, we highlight the importance of integrating clinicians, the public and cancer patients early on in the development of these novel technologies.
| Identifer | oai:union.ndltd.org:DRESDEN/oai:qucosa:de:qucosa:80042 |
| Date | 22 July 2022 |
| Creators | Schmidt, Christine K., Medina-Sánchez, Mariana, Edmondson, Richard J., Schmidt, Oliver G. |
| Publisher | Technische Universität Chemnitz, Springer Nature |
| Source Sets | Hochschulschriftenserver (HSSS) der SLUB Dresden |
| Language | English |
| Detected Language | English |
| Type | info:eu-repo/semantics/publishedVersion, doc-type:article, info:eu-repo/semantics/article, doc-type:Text |
| Rights | info:eu-repo/semantics/openAccess |
| Relation | 2041-1723, 5618, 10.1038/s41467-020-19322-7, info:eu-repo/grantAgreement/European Research Council/Horizon 2020/835268, 853609/ |
Page generated in 0.0024 seconds